The Tisch Cancer Institute Cancer Prevention and Control (CPC) Program encompasses a rich and complementary array of research projects in the areas of cancer prevention, control, and care delivery. Its overarching goals are to reduce the burden of cancer incidence and mortality, and to improve the life of people affected by the disease. Projects within CPC are developed along the cancer continuum from primary prevention to early diagnosis, treatment, and follow-up. CPC projects are characterized by the integration of expertise across disciplines, including clinical sciences, molecular biology and genetics, epidemiology, health services research, and health psychology.
Two cross-cutting themes characterize research within CPC. Many projects within CPC address disparities in cancer risks and outcomes: They are conducted in special populations, such as ethnic minorities and individuals exposed to the World Trade Center attack and its aftermath, which can experience a disproportionate burden of cancer. In addition, major CPC research projects are based on multi-institution consortia collaborations, both nationally and internationally, in which CPC members play a key coordinating role.
The CPC program is organized along three research themes:
- Research on new methods of early diagnosis and screening of cancer and on approaches to enhance participation, in particular among minority groups
- Molecular cancer epidemiology research, including studies in special populations, and molecular-oriented studies addressing mechanistic aspects of carcinogenesis relevant to prevention
- Research aimed at improving the quality and delivery of cancer care, including comparative effectiveness and costs of interventions in diverse populations and settings, and understanding and reducing negative sequelae of cancer via individual, familial, and community engagement strategies